BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25003724)

  • 1. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
    Sukasem C; Puangpetch A; Medhasi S; Tassaneeyakul W
    Asian Pac J Allergy Immunol; 2014 Jun; 32(2):111-23. PubMed ID: 25003724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
    Borroni RG
    G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.
    Negrini S; Becquemont L
    Pharmacogenomics; 2017 Oct; 18(15):1441-1457. PubMed ID: 29017379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
    Gerogianni K; Tsezou A; Dimas K
    Mol Diagn Ther; 2018 Jun; 22(3):297-314. PubMed ID: 29564734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotyping
    Jantararoungtong T; Tempark T; Koomdee N; Medhasi S; Sukasem C
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1049-1064. PubMed ID: 34148467
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA and pharmacogenetics of drug hypersensitivity.
    Pavlos R; Mallal S; Phillips E
    Pharmacogenomics; 2012 Aug; 13(11):1285-306. PubMed ID: 22920398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic information derived from analysis of HLA alleles.
    Gatanaga H; Honda H; Oka S
    Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study].
    Mushiroda T
    Rinsho Byori; 2014 Jan; 62(1):83-8. PubMed ID: 24724431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recent update of pharmacogenomics in drug-induced severe skin reactions.
    Wei CY; Ko TM; Shen CY; Chen YT
    Drug Metab Pharmacokinet; 2012; 27(1):132-41. PubMed ID: 22041139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on HLA alleles associated with adverse drug reactions.
    Fricke-Galindo I; LLerena A; López-López M
    Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenomics of severe drug hypersensitivity reactions--from bench to bedside].
    Porębski G; Dyga W; Stobiecki M; Czarnobilska E
    Przegl Lek; 2015; 72(12):779-82. PubMed ID: 27024960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of allopurinol--making an old drug safer.
    Lam MP; Yeung CK; Cheung BM
    J Clin Pharmacol; 2013 Jul; 53(7):675-9. PubMed ID: 23381951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic markers of severe cutaneous adverse reactions.
    Jung JW; Kim JY; Park IW; Choi BW; Kang HR
    Korean J Intern Med; 2018 Sep; 33(5):867-875. PubMed ID: 29921043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of idiosyncratic adverse drug reactions.
    Pirmohamed M
    Handb Exp Pharmacol; 2010; (196):477-91. PubMed ID: 20020273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dermatology in pharmacogenomics: drug-induced skin injury.
    Borroni RG
    Pharmacogenomics; 2015; 16(4):401-12. PubMed ID: 25823788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.
    Jarjour S; Barrette M; Normand V; Rouleau JL; Dubé MP; de Denus S
    Pharmacogenomics; 2015; 16(7):755-67. PubMed ID: 25965122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.